Cargando…
Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes
Effects of metformin, the first-line drug for type 2 diabetes therapy, on gut microbiome composition in type 2 diabetes have been described in various studies both in human subjects and animals. However, the details of the molecular mechanisms of metformin action have not been fully understood. More...
Autores principales: | Silamiķele, Laila, Silamiķelis, Ivars, Ustinova, Monta, Kalniņa, Zane, Elbere, Ilze, Petrovska, Ramona, Kalniņa, Ineta, Kloviņš, Jānis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018580/ https://www.ncbi.nlm.nih.gov/pubmed/33815284 http://dx.doi.org/10.3389/fendo.2021.626359 |
Ejemplares similares
-
Spatial variation of the gut microbiome in response to long-term metformin treatment in high-fat diet-induced type 2 diabetes mouse model of both sexes
por: Silamiķele, Laila, et al.
Publicado: (2023) -
Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance
por: Brīvība, Monta, et al.
Publicado: (2023) -
Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response
por: Ustinova, Monta, et al.
Publicado: (2020) -
Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients
por: Elbere, Ilze, et al.
Publicado: (2020) -
Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals
por: Ustinova, Monta, et al.
Publicado: (2019)